What is Thalys Medical Technology Group Corporation's (603716.SS) StockRank?

MoatMap's StockRank for Thalys Medical Technology Group Corporation (603716.SS) is 31/100, with a Sell signal. This is a composite score combining Quality (37), Value (52), and Momentum (34) factor ranks across MoatMap's 20,000+ stock universe.

Does Thalys Medical Technology Group Corporation have an economic moat?

Thalys Medical Technology Group Corporation (603716.SS) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the financial characteristics of a moated business.

Is Thalys Medical Technology Group Corporation a buy, hold, or sell?

MoatMap's current signal for Thalys Medical Technology Group Corporation (603716.SS) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.

What sector is Thalys Medical Technology Group Corporation in?

Thalys Medical Technology Group Corporation (603716.SS) operates in the Healthcare sector, specifically the Diagnostics & Research industry (China).

Company Deep Dive

Business segments breakdown, earnings transcript analysis, management credibility scoring, competitive landscape, and scenario modelling.

Request Deep Dive(50 Feathers)

603716.SS

SELLREMOVE

Thalys Medical Technology Group Corporation · Healthcare · China · $568M · Avg Vol: $19M/d

StockRank

P/E (TTM)

—

ROE

-21.5%

D/E

0.4x

Dividend %

—

Director Trades · 180d

None in 180d →

Buybacks · 180d

None in 180d →

AI CONVICTION THESIS

Thalys Medical Technology is a Chinese medical distributor. It operates in a low-margin, highly regulated distribution sector with low quality metrics (Q-score: 40) and lacks any proprietary technology or pricing power.

COMPANY DESCRIPTION

Thalys Medical Technology Group is a prominent Chinese distributor of in vitro diagnostic (IVD) products and a provider of centralized purchasing and laboratory management services for hospitals. The company maintains a strong market position through its extensive distribution network and its innovative 'SPD' (Supply, Processing, and Distribution) logistics model for medical consumables. Its competitive edge lies in its deep integration with healthcare institutions, offering them cost-reduction and supply chain optimization solutions.

FINANCIAL SUMMARY (USD)

Year	2022	2023	2024	2025	CAGR
Revenue	341M	296M	268M	159M	-22.4%
EPS	-0.12	-0.12	-0.16	-0.15	—
Shares	204M	202M	191M	210M	+3.3%
Debt	212M	155M	138M	67M	-31.8%
Equity	207M	179M	138M	140M	-12.3%
Op CF	4M	19M	15M	-6M	88.2%
Inv CF	24M	2M	-1M	4M	—
Fin CF	-47M	-32M	-22M	-12M	—

PRICE (1M)-28.3%

SMA 50SMA 200

$2.30

RSI (14)

26.9

52W High

$5.63

From 52W High

0.4%

SCORE BREAKDOWN

Quality

ROIC

-12.8%32.4

ROE

-21.5%29.0

GP/Assets

11.6%28.9

Op. Margin

-6.2%31.4

FCF/Assets

13.3%91.9

Piotroski

—28.7

Int. Cover

-3.5x32.0

D/E Ratio

0.38x37.8

Current Ratio

1.61x28.4

Value

P/E (TTM)

—N/A

EV/EBITDA

-89.1x95.8

P/FCF

109.3x69.3

P/B

3.4x35.4

P/S

3.7x49.7

Div Yield

—N/A

Momentum

52W High %

41%13.3

RS 6M

-37%33.5

SMA 50/200

0.85x21.5

EPS Rev 4W

—N/A

EPS Rev 12W

—N/A

EPS Improve

+189%86.7

Q Growth

—N/A

FUNDAMENTALS

Market Cap

$568M

P/E (Forward)

17.1x

Gross Margin

21.4%

SECTOR PEERS

Closest peers in Healthcare, ranked by industry match, size, and score similarity. Cross-listings of 603716.SS are excluded.

Ticker	Company	Mkt Cap	StockRank	Signal
603716.SS	Thalys Medical Technology Group Corporation(you)	$568M	31	SELL
9860.HK	Adicon Holdings Limited	$394M	32	SELL
300463.SZ	Maccura Biotechnology Co.Ltd	$845M	33	SELL
2427.HK	Guanze Medical Information Industry (Holding) Co., Ltd.	$526M	42	HOLD
603108.SS	Shanghai Runda Medical Technology Co., Ltd.	$1.1B	21	SELL
300676.SZ	BGI Genomics Co., Ltd.	$2.3B	37	HOLD
3347.HK	Hangzhou Tigermed Consulting Co., Ltd	$3.4B	41	HOLD
8247.HK	Biosino Bio-Technology and Science Incorporation	$55M	23	SELL
603882.SS	Guangzhou Kingmed Diagnostics Group Co., Ltd.	$1.8B	67	BUY
BNR	Burning Rock Biotech Limited	$107M	5	STRONG SELL

Peer medians: ROE 4.8% · P/E 27.8x · Gross margin 53.1%

Thalys Medical Technology Group Corporation (603716.SS) — Stock Score Summary

Thalys Medical Technology Group Corporation (603716.SS) has a MoatMap StockRank of 31/100 based on Quality (37/100), Value (52/100), and Momentum (34/100) factor scores. The current signal is SELL. Thalys Medical Technology is a Chinese medical distributor. It operates in a low-margin, highly regulated distribution sector with low quality metrics (Q-score: 40) and lacks any proprietary technology or pricing power.

Key Financial Metrics

Price	$2.30
Market Cap	$568M
P/E (Forward)	17.08
Price/Book	3.39
Return on Equity	-21.5%
Return on Invested Capital	-12.8%
Debt/Equity	38.16
Gross Margin	21.4%
Operating Margin	-6.2%
Revenue Growth	-36.8%
Free Cash Flow	$5M

Thalys Medical Technology Group Corporation operates in the Diagnostics & Research industry, part of the Healthcare sector (China).

Frequently Asked Questions

What is Thalys Medical Technology Group Corporation’s (603716.SS) StockRank?: MoatMap’s StockRank for Thalys Medical Technology Group Corporation (603716.SS) is 31/100, with a Sell signal. It is a composite of Quality (37), Value (52), and Momentum (34) factor ranks across MoatMap’s 20,000+ stock universe.
Does Thalys Medical Technology Group Corporation have an economic moat?: Thalys Medical Technology Group Corporation (603716.SS) has a Quality factor score of 37/100. The Quality factor combines ROIC, Piotroski F-Score, and leverage — the financial fingerprints of a durable competitive advantage. A Quality score above 70 typically indicates a company with the characteristics of a moated business.
Is Thalys Medical Technology Group Corporation a buy, hold, or sell?: MoatMap’s current signal for Thalys Medical Technology Group Corporation (603716.SS) is Sell, based on a StockRank of 31/100. Signals are derived mechanically from the StockRank composite and should be one input among many — combine with your own thesis on management, competitive position, and valuation.
What sector is Thalys Medical Technology Group Corporation in?: Thalys Medical Technology Group Corporation (603716.SS) operates in the Healthcare sector, specifically the Diagnostics & Research industry (China).